Shilpa Medicare's 38th AGM approves dividend, director appointments, bonus shares

Shilpa Medicare Limited held its 38th Annual General Meeting (AGM) on Tuesday, September 23, 2025, through video conferencing. The meeting saw the approval of audited standalone and consolidated financial statements for the fiscal year ended March 31, 2025.

Shareholders also approved a dividend of INR 1.00 per equity share for the financial year ended March 31, 2025. Other key resolutions included the re-appointment of Omprakash Inani as director and Sharath Reddy Kalakota as whole time director. The appointment of Dr. Anita Bandyopadhyay and Ashraf Loutfy Abdelhamid Allam as independent directors was also approved.

The company further addressed the revision in remuneration for Keshav Bhutada as executive director & CEO in Shilpa Pharma Lifesciences Ltd., a material subsidiary. D S Rao was appointed as secretarial auditor for a five-year term, and the issue of bonus shares was also approved by the members.